2024 American Academy of Neurology Abstract Website

Disclosures for "Serum Glial Fibrillary Acidic Protein as a Predictive Marker for Developing Central Vein Sign Lesions in Radiologically Isolated Syndrome"

Mrs. Brand-Arzamendi has nothing to disclose.
Timothy R. Lim has nothing to disclose.
Lisa Eunyoung Lee has nothing to disclose.
Melanie Guenette has nothing to disclose.
Dr. Suthiphosuwan has nothing to disclose.
Dr. Bharatha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Dr. Schneider has nothing to disclose.